Saturday 17 October 2026
Export ATEC’s income statement to Excel — free account
Alphatec Holdings, Inc.
ATEC Healthcare Medical Devices
Alphatec Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $764.2 million, up 25.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 40.7%, free cash flow fell 146.9% and total debt fell 7.79%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
10.45
0.48
−4.39%
Follow ATEC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 4 | 4 | 5 | 3 | 5 | 3 | 5 | 6 |
P/S ratio |
0.23 | 0.34 | 0.88 | 3.27 | 6.72 | 4.52 | 3.49 | 3.73 | 2.15 | 4.13 |
Altman Z-Score |
(5.52) | (6.04) | (4.44) | (2.59) | 1.42 | (0.41) | (1.12) | (0.11) | (0.70) | 0.89 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(14.96) | (15.81) | (11.36) | (9.45) | (5.28) | (3.16) | (6.33) | (3.47) | (4.35) | (4.63) |
Beneish M-Score |
(3.77) | (2.42) | (0.93) | (3.14) | (2.68) | (2.44) | (2.80) | (2.86) | (3.13) | (3.43) |
P/Operating CF |
(2.81) | (55.52) | (8.90) | (40.90) | (144.64) | (74.59) | (145.53) | (72.01) | 124.70 | 152.66 |
P/B ratio |
0.00 | 0.00 | 4.60 | 8.50 | 7.49 | 13.84 | 0.00 | 23.05 | 0.00 | 254.09 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 89.82 | 10.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.45 | 0.52 | 1.06 | 3.33 | 6.27 | 5.11 | 4.30 | 4.34 | 2.86 | 4.66 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 155.25 |
EV/Operating CF |
(5.45) | (6.04) | (3.80) | (11.40) | (19.57) | (16.96) | (20.06) | (26.66) | (39.18) | 78.76 |
EV/FCF |
(2.97) | (3.30) | (2.99) | (8.05) | (12.84) | (8.70) | (11.30) | (12.65) | (12.70) | (807.85) |
Quick Ratio |
0.95 | 1.25 | 1.45 | 1.74 | 2.27 | 2.27 | 1.04 | 1.86 | 1.45 | 1.18 |
Current Ratio |
1.81 | 2.24 | 2.47 | 2.98 | 3.16 | 3.28 | 1.84 | 2.86 | 2.73 | 2.06 |
Net Debt/EBITDA |
(32.30) | (12.23) | (1.06) | (0.18) | 1.37 | (1.50) | (2.82) | (2.65) | (9.04) | 14.84 |
Debt/Assets |
49.06% | 48.52% | 35.20% | 31.74% | 16.49% | 57.87% | 70.89% | 63.69% | 74.28% | 63.37% |
Debt/Equity |
(1.11) | (1.54) | 2.59 | 1.24 | 0.33 | 4.17 | (10.65) | 6.57 | (40.66) | 40.35 |
Asset Turnover |
1.00 | 1.14 | 0.86 | 0.76 | 0.67 | 0.58 | 0.64 | 0.73 | 0.77 | 0.98 |
Operating CF/Net income |
0.33 | 3.81 | 0.60 | 0.58 | 0.59 | 0.51 | 0.50 | 0.42 | 0.28 | (0.32) |
Capex/Depreciation |
(0.54) | (0.87) | (0.91) | (1.53) | (2.05) | (2.14) | (1.27) | (1.37) | (1.06) | (0.47) |
Interest Coverage |
(2.87) | (1.18) | (3.14) | (4.79) | (4.76) | (18.02) | (26.70) | (10.42) | (5.47) | (1.79) |
| 76.65% | 6.73% | 934.91% | (186.27%) | (91.05%) | (136.68%) | (676.09%) | (859.11%) | (507.05%) | 16,450.51% | |
| (24.88%) | (2.57%) | (39.66%) | (38.07%) | (36.64%) | (34.33%) | (27.68%) | (28.15%) | (20.51%) | (18.30%) | |
ROIC |
0.00% | 0.00% | (41.14%) | (58.56%) | (56.43%) | (35.86%) | (36.75%) | (29.29%) | (20.11%) | (14.54%) |
Return on Tangible Assets |
(62.65%) | (4.64%) | (73.01%) | (62.20%) | (48.61%) | (45.05%) | (69.17%) | (42.10%) | (38.53%) | (39.06%) |
Average Days of Receivables |
56.19 | 53.18 | 61.48 | 51.97 | 61.99 | 62.87 | 62.48 | 54.96 | 49.53 | 46.48 |
Research and Development Expense of Revenue |
7.69% | 4.84% | 10.75% | 12.21% | 12.94% | 13.16% | 12.55% | 14.54% | 13.20% | 9.98% |
Selling, General and Administrative Expense of Revenue |
64.28% | 68.76% | 79.22% | 89.67% | 89.16% | 94.27% | 85.51% | 77.57% | 73.61% | 65.24% |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.31 | 0.23 | 0.15 | 0.22 | 0.25 | 0.22 | 0.21 | 0.21 |
Share Based Compensation of Revenue |
1.35% | 3.91% | 5.78% | 9.66% | 12.19% | 14.99% | 11.56% | 16.85% | 11.98% | 9.65% |
Graham Net Nets |
(2.27) | (1.31) | (0.45) | (0.05) | 0.05 | (0.15) | (0.25) | (0.15) | (0.28) | (0.10) |
Graham Number |
19.79 | 5.08 | 0.00 | 0.00 | 0.00 | 0.00 | 3.33 | 0.00 | 1.59 | 0.00 |
Earnings Yield |
(111.81%) | (20.60%) | (33.62%) | (15.49%) | (8.06%) | (12.95%) | (12.43%) | (10.44%) | (12.42%) | (4.52%) |
Free Cash Flow Yield |
(66.19%) | (46.78%) | (40.22%) | (12.65%) | (7.27%) | (12.99%) | (10.91%) | (9.19%) | (10.50%) | (0.14%) |
Revenue per Share |
14.01 | 7.96 | 2.60 | 2.17 | 2.16 | 2.53 | 3.39 | 3.98 | 4.28 | 5.09 |
Operating CF per Share |
(1.16) | (0.68) | (0.73) | (0.63) | (0.69) | (0.76) | (0.73) | (0.65) | (0.31) | 0.30 |
Capex per Share |
(0.91) | (0.51) | (0.17) | (0.25) | (0.36) | (0.71) | (0.56) | (0.72) | (0.65) | (0.33) |
Free Cash Flow per Share |
(2.07) | (1.19) | (0.90) | (0.88) | (1.05) | (1.47) | (1.29) | (1.36) | (0.96) | (0.03) |
Cash per Share |
2.28 | 1.76 | 0.82 | 0.90 | 1.61 | 1.95 | 0.82 | 1.82 | 0.97 | 1.07 |
Shareholders Equity per Share |
(4.84) | (2.08) | 0.50 | 0.84 | 1.94 | 0.83 | (0.34) | 0.64 | (0.10) | 0.08 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(4.84) | (2.08) | 0.50 | 0.84 | 1.94 | 0.83 | (0.34) | 0.64 | (0.10) | 0.08 |
Free Cash Flow |
(17.79) | (15.22) | (31.77) | (46.15) | (70.27) | (141.86) | (133.41) | (165.46) | (137.79) | (4.41) |
Working Capital |
32.69 | 36.74 | 44.92 | 71.93 | 125.85 | 230.06 | 116.76 | 293.52 | 264.37 | 231.70 |
Capital Expenditures |
(7.83) | (6.49) | (6.17) | (13.03) | (23.86) | (68.54) | (58.28) | (86.97) | (93.14) | (49.64) |
Net Current Asset Value |
(62.87) | (44.84) | (36.37) | (18.00) | 52.82 | (161.47) | (300.00) | (276.00) | (372.48) | (327.91) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.07 | 0.06 | 0.07 | 0.11 | 0.16 | 0.28 | 0.17 | 0.18 | 0.15 | 0.07 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.97 | 0.59 | 0.51 | 0.43 | 0.32 | 0.37 | 0.45 | 0.42 | 0.56 | 0.78 |
Cash ROIC |
(73.23%) | (41.28%) | (34.46%) | (31.90%) | (25.03%) | (23.73%) | (31.82%) | (20.38%) | (19.66%) | (0.65%) |
Accounts Receivable Turnover |
5.30 | 6.10 | 6.06 | 7.18 | 7.11 | 7.32 | 6.88 | 7.27 | 7.86 | 8.48 |
Accounts Payable Turnover |
3.97 | 5.33 | 6.88 | 5.89 | 3.34 | 3.94 | 3.90 | 4.45 | 3.99 | 5.27 |
Inventory Turnover |
1.41 | 1.17 | 1.02 | 1.13 | 1.05 | 1.24 | 1.22 | 1.56 | 1.30 | 1.44 |
Average Days of Payables |
71.99 | 42.23 | 56.42 | 79.17 | 151.64 | 109.94 | 107.64 | 95.95 | 95.01 | 60.35 |
Days of Inventory on Hand |
248.99 | 297.21 | 368.95 | 355.03 | 396.37 | 391.71 | 314.54 | 268.04 | 314.27 | 250.06 |
Average Receivables |
22.69 | 16.67 | 15.13 | 15.80 | 20.38 | 33.25 | 50.98 | 66.34 | 77.80 | 90.15 |
Average Payables |
11.12 | 6.29 | 4.14 | 6.09 | 12.69 | 21.67 | 30.24 | 41.86 | 50.98 | 46.94 |
Average Inventory |
31.36 | 28.69 | 28.03 | 31.81 | 40.43 | 68.85 | 96.61 | 119.18 | 156.05 | 172.35 |
Average Assets |
120.26 | 89.42 | 107.07 | 149.71 | 215.59 | 416.64 | 546.51 | 663.09 | 790.46 | 783.46 |
Average Common Equity |
(39.04) | (34.08) | (4.54) | 30.60 | 86.76 | 104.65 | 22.38 | 21.72 | 31.97 | (0.87) |
Columns are period end dates